Back to mobile site

RBC Capital on Bausch & Lomb Corp. (BLCO): 'Rx DED momentum drives estimates higher'

October 8, 2026 8:04 AM EDT Send to a Friend
RBC Capital analyst Douglas Miehm reiterated an Outperform rating and $21.00 price target on Bausch & Lomb Corp. (NYSE: BLCO).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login